tirzepatide-cyanocobalamin Compounded versions of tirzepatide (Mounjaro, Zepbound) containing vitamin B12 pose a potential safety risk to the public, Eli Lilly warned in an open letter on Thursday. Following laboratory testing, the drugmaker said Compound Tirzepatide with B12 *Cold

These studies are required by the FDA to ensure that the drug is effective in treating a specific Disease condition and is also safe for human use

Proactive strategies include: Educational content about insurance and copay programs Payer engagement with real-world outcome data Community-based outreach that addresses underserved populations Failing to address these realities risks alienating the very patients who could benefit most

Federal officials recently announced plans to make these medications more accessible and affordable, including to people who have Medicare, which currently does not cover medications strictly for weight loss

Come prepared with your medical history, medication list, and clear goals for treatment